Paul Matteis's
Stock Forecasts

Paul Matteis win rate

22.22%

4/18 win trades

Paul Matteis is a Wall Street stock analyst with a 22.22% win rate, who was right in predicting 4 out of 18 price targets. Most frequently covered stocks by this analyst are NGNE, ALKS, BMRN and ALNY. He has published 0 price targets in the last month and 4 last year.

Price targets by Paul Matteis

Company name & ticker	Publish date	Price target	Price when posted	Source	Historical targets
Neurogene Inc. NGNE	20 Nov 2024 9 months ago	$46 133.50% upside	$15.33	StreetInsider
Alkermes plc ALKS	4 Nov 2024 10 months ago	$36 24.13% upside	$26.59	StreetInsider
BioMarin Pharmaceutical Inc. BMRN	21 Aug 2024 about 1 year ago	$115 101.75% upside	$93.84	TheFly
Alnylam Pharmaceuticals, Inc. ALNY	27 Jun 2024 about 1 year ago	$295 -34.31% downside	$247.4	StreetInsider
Ionis Pharmaceuticals, Inc. IONS	27 Jun 2024 about 1 year ago	$53 24.76% upside	$47.7	TheFly	Previous targets (0)
Biogen Inc. BIIB	22 May 2024 over 1 year ago	$275 98.19% upside	$225.21	StreetInsider	Previous targets (0)
Dyne Therapeutics, Inc. DYN	20 May 2024 over 1 year ago	$41 234.69% upside	$27.68	StreetInsider	Previous targets (0)
Contineum Therapeutics, Inc. Class A Common Stock CTNM	30 Apr 2024 over 1 year ago	$29 211.82% upside	$16	StreetInsider	Previous targets (0)
Neumora Therapeutics, Inc. Common Stock NMRA	10 Oct 2023 almost 2 years ago	$26 1475.66% upside	$10.91	Benzinga	Previous targets (0)